We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+8.3%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$3.67B
AUM Growth
+$440M
Cap. Flow
+$220M
Cap. Flow %
5.99%
Top 10 Hldgs %
43.08%
Holding
423
New
55
Increased
207
Reduced
129
Closed
10
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WCC
401
WESCO International
WCC
$16.7B
$205K 0.01%
+1,109
New +$183K
GAM
402
General American Investors Company
GAM
$1.56B
$202K 0.01%
+3,602
New +$188K
DMRC icon
403
Digimarc Corp
DMRC
$147M
$175K ﹤0.01%
13,271
IBRX icon
404
ImmunityBio
IBRX
$7.51B
$154K ﹤0.01%
58,436
+48,436
+484% +$130K
F icon
405
Ford
F
$58.5B
$139K ﹤0.01%
+12,846
New +$131K
FOLD
406
DELISTED
Amicus Therapeutics
FOLD
$137K ﹤0.01%
23,927
+717
+3% +$4.63K
EQX icon
407
Equinox Gold
EQX
$7.06B
$123K ﹤0.01%
21,400
UROY
408
Uranium Royalty Corp
UROY
$1.3B
$75K ﹤0.01%
30,000
AUR icon
409
Aurora
AUR
$12.6B
$68.1K ﹤0.01%
13,000
+2,000
+18% +$12.5K
IOVA icon
410
Iovance Biotherapeutics
IOVA
$1.82B
$65.1K ﹤0.01%
37,839
+5,672
+18% +$14.1K
RBBN icon
411
Ribbon Communications
RBBN
$377M
$40.2K ﹤0.01%
10,030
IRWD icon
412
Ironwood Pharmaceuticals
IRWD
$696M
$29.4K ﹤0.01%
40,994
LCID icon
413
Lucid Motors
LCID
$2.88B
$23.2K ﹤0.01%
1,100
ALB icon
414
Albemarle
ALB
$13.9B
-4,029
Closed -$290K
CLM icon
415
Cornerstone Strategic Value Fund
CLM
$2.22B
-45,604
Closed -$334K
CRF
416
Cornerstone Total Return Fund
CRF
$1.16B
-26,766
Closed -$188K
DD icon
417
DuPont de Nemours
DD
$18.5B
-2,390
Closed -$224K
ELV icon
418
Elevance Health
ELV
$81.5B
-462
Closed -$201K
FBIN icon
419
Fortune Brands Innovations
FBIN
$5.88B
-3,575
Closed -$218K
HIPS icon
420
GraniteShares HIPS US High Income ETF
HIPS
$109M
-67,370
Closed -$857K
IWS icon
421
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
-1,607
Closed -$202K
MRSN
422
DELISTED
Mersana Therapeutics
MRSN
-563
Closed -$4.84K
PJP icon
423
Invesco Pharmaceuticals ETF
PJP
$442M
-3,492
Closed -$302K

Similar funds

Grimes & Company's Q2 2025 Portfolio in Review

As of Q2 2025, Grimes & Company held 423 positions worth $3.67B, up 14% from $3.23B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Grimes & Company deployed $220M of net new capital in Q2 2025, opening 55 new positions and adding to 207 existing holdings. Its largest new stake was State Street SPDR Portfolio High Yield Bond ETF: 7,014,494 shares worth $167M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Invesco Senior Loan ETF, an estimated $209M trimmed.

  • Grimes & Company's largest Q2 2025 buy was State Street SPDR Portfolio High Yield Bond ETF: 7,014,494 shares worth $167M.
  • Grimes & Company added most to iShares Core MSCI EAFE ETF in Q2 2025, an estimated $124M increase.
  • Grimes & Company's biggest Q2 2025 reduction was Invesco Senior Loan ETF, cutting an estimated $209M.
  • Grimes & Company fully exited GraniteShares HIPS US High Income ETF in Q2 2025, selling an estimated $857K.
  • Grimes & Company's ten largest holdings make up 43% of its $3.67B portfolio in Q2 2025.
  • Grimes & Company opened 55 new positions and closed 10 in Q2 2025.
  • Grimes & Company's portfolio value rose 14% quarter-over-quarter to $3.67B.

Based on Grimes & Company's 13F filing for Q2 2025, filed 22 Jul 2025.